Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Oct 10;12(10):e1005903. doi: 10.1371/journal.ppat.1005903

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2016 van Aalderen et al

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.

PMC Copyright notice

Fig 1 — (A) anti-VP1 antibody levels in NR, R^low, R^high and BKVN patients shortly before transplantation and one year after transplantation. (B) Viral load during follow-up of R^low, R^high and BKVN patients (left panel) and viral load plotted against the peak viral load (right panel). (C) From left to right: Population sizes of VP1- (open symbols) and LTAG-specific (closed symbols) CD8⁺ T cells detected in healthy individuals, in all RTRs before transplantation, in NR patients before—and one year after transplantation and in the R^low, R^high and BKVN during follow-up. (D) Expression frequency of Ki-67 by VP1- (open symbols) and LTAG-specific (closed symbols) CD8⁺ T cells in healthy individuals, in NR patients before—and one year after transplantation and in the R^low, R^high and BKVN RTRs during follow-up.